4A4B11
4A4B11
规格:
货期:
编号:TS212867
品牌:Testobio
| 产品名称： | 4A4B11 |
|---|---|
| 商品货号： | TS212867 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with purified human C1q. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human complement C1q |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human complement C1q |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in pristane primed BALB/c mice |
| Comments： | Animals were immunized with purified human C1q. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Complete Growth Medium： | Culture Medium: RPMI 1640 medium with 10(-4) M hypoxanthine and 1.6 x 10(-5) M thymidine, 90%; fetal bovine serum, 10%. |
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG |
| Name of Depositor： | Immunomedics, Inc. |
| U.S. Patent Number： | |
| References： | Reckel RP, et al. Method for detecting immune complexes in serum. US Patent 4,595,654 dated Jun 17 1986 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
4A4B11
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | 4A4B11 |
|---|---|
| 商品货号： | TS212867 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with purified human C1q. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human complement C1q |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human complement C1q |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in pristane primed BALB/c mice |
| Comments： | Animals were immunized with purified human C1q. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Complete Growth Medium： | Culture Medium: RPMI 1640 medium with 10(-4) M hypoxanthine and 1.6 x 10(-5) M thymidine, 90%; fetal bovine serum, 10%. |
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG |
| Name of Depositor： | Immunomedics, Inc. |
| U.S. Patent Number： | |
| References： | Reckel RP, et al. Method for detecting immune complexes in serum. US Patent 4,595,654 dated Jun 17 1986 |
